Japan, Sept. 18 -- JANSSEN PHARMACEUTICALS INC,AC IMMUNE SA has got intellectual property rights for 'METHOD FOR SAFE ADMINISTRATION OF PHOSPHORYLATED TAU PEPTIDE VACCINE.' Other related details are as follows:

Application Number: JP,2024-136910

Category (FI): C12N15/117@Z,A61P25/28,A61K31/7016,A61K31/7125,A61K45/00,A61K39/395@N,A61K39/00@Z,A61K9/127,A61K47/42,A61K47/26,A61K47/24,A61K47/28,C12N15/12,C07K14/46,A61K31/7088,A61K47/60,A61K39/39,A61K38/08,A61K38/10,A61K38/16,C07K14/47,C07K14/195

Stage: PROBLEM TO BE SOLVED: To provide methods for inducing anti-phosphorylated Tau antibodies without inducing a severe adverse event in humans.SOLUTION: The methods include administering to the subject an effective amount of liposomes including a t...